About site:

Domain name - aducanumab.be

Site title - Site Title Unavailable

Go to website - Link to aducanumab.be was blocked

Site Logo

IP address:

165.160.15.20 165.160.13.20

Domain name servers:

dns2.cscdns.net dns1.cscdns.net

All records:

☆ aducanumab.be. 3592 IN HINFO "RFC8482" ""

%
% The WHOIS service offered by DNS Belgium and the access to the records in the DNS Belgium
% WHOIS database are provided for information purposes only. It allows
% persons to check whether a specific domain name is still available or not
% and to obtain information related to the registration records of
% existing domain names.
%
% DNS Belgium cannot, under any circumstances, be held liable where the stored
% information would prove to be incomplete or inaccurate in any sense.
%
% By submitting a query you agree not to use the information made available
% to:
% - allow, enable or otherwise support the transmission of unsolicited,
% commercial advertising or other solicitations whether via email or otherwise;
% - target advertising in any possible way;
% - to cause nuisance in any possible way to the domain name holders by sending
% messages to them (whether by automated, electronic processes capable of
% enabling high volumes or other possible means).
%
% Without prejudice to the above, it is explicitly forbidden to extract, copy
% and/or use or re-utilise in any form and by any means (electronically or
% not) the whole or a quantitatively or qualitatively substantial part
% of the contents of the WHOIS database without prior and explicit permission
% by DNS Belgium, nor in any attempt thereof, to apply automated, electronic
% processes to DNS Belgium (or its systems).
%
% You agree that any reproduction and/or transmission of data for commercial
% purposes will always be considered as the extraction of a substantial
% part of the content of the WHOIS database.
%
% By submitting the query you agree to abide by this policy and accept that
% DNS Belgium can take measures to limit the use of its whois services in order to
% protect the privacy of its registrants or the integrity of the database.
%

Domain: aducanumab.be
Status: NOT AVAILABLE
Registered: Fri Apr 21 2017

Registrant:
Not shown, please visit www.dnsbelgium.be for webbased whois.

Registrar Technical Contacts:
Organisation: CSC Corporate Domains, Inc.
Language: en
Phone: +1.3026365400


Registrar:
Name: CSC Corporate Domains, Inc.
Website: https://www.cscdigitalbrand.services/

Nameservers:
dns2.cscdns.net
dns1.cscdns.net

Keys:

Flags:
clientTransferProhibited

Please visit www.dnsbelgium.be for more info.

Brief facts about aducanumab:

Aducanumab, sold under the brand name Aduhelm, is a medication designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms of amyloid beta found in the brains of people with Alzheimer's disease to reduce its buildup. It was developed by Biogen and Eisai. Aducanumab is given via intravenous infusion. Aducanumab was approved for medical use in the United States by the Food and Drug Administration in June 2021, in a controversial decision that led to the resignation of three advisers to the FDA in the absence of evidence that the medication is effective. The FDA stated that it represents a first-of-its-kind treatment approved for Alzheimer's disease and that it is the first new treatment approved for Alzheimer's since 2003. Aducanumab's approval is controversial for numerous reasons including ambiguous clinical trial results regarding efficacy, the high cost of the medication and the very high rate of serious adverse events.

Withdrawn drugs